Ardelyx, Inc.

Ardelyx is a biopharmaceutical company focused on creating first-in-class medicines to meet unmet medical needs. The company specializes in therapeutic areas such as chronic kidney disease with hyperphosphatemia and irritable bowel syndrome with constipation (IBS-C). Ardelyx is committed to patient care, innovation, and collaboration with the community, aiming to improve quality of life for patients through novel treatments. With core values of fearlessness, passion, dedication, and inclusivity, Ardelyx fosters a respectful and inclusive workplace. The company is engaged in clinical trials and partnerships to support its mission of patient-centered medical advancement.